Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Keyword Search:
Clear search
1
–
15
of
19
results
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | SCF |
| Molecular Weight (g/mol) | 18.4 kDa |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | MEGICRNRVT NNVKDVTKLV ANLPKDYMIT LKYVPGMDVL PSHCWISEMV VQLSDSLTDL LDKFSNISEG LSNYSIIDKL VNIVDDLVEC VKENSSKDLK KSFKSPEPRL FTPEEFFRIF NRSIDAFKDF VVASETSDCV VSSTLSPEKD SRVSVTKPFM LPPVA |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human SCF |
| Accession Number | P21583 |
| Regulatory Status | GMP |
| Gene Alias | 710-712; blz; c-Kit ligand; Clo; cloud gray; Con; contrasted; CSF; DCUA; DFNA69; DKFZp686F2250; familial progressive hyperpigmentation 2; FPH2; FPHH; Gb; grizzle-belly; hematopoietic growth factor KL; H-SCF; Kit ligand; Kitl; Kitlg; kit-ligand; KL-1; Mast cell growth factor; MGF; M-SCF; Processed kit ligand; SCF; SF; SHEP7; sKITLG; Sl; SLF; Soluble KIT ligand; Steel factor; steel factor/kit ligand; stem cell factor; stem cell factor KL-1; stem cell factor, CSF |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of TF-1 cells. PeproGMP Recombinant Human SCF has been tested against the WHO standard NIBSC 91/682. |
| Gene ID (Entrez) | 4254 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | LIF |
| Molecular Weight (g/mol) | 19.7 kDa |
| Activity | Determined by the proliferation of TF-1 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SPLPITPVNA TCAIRHPCHN NLMNQIRSQL AQLNGSANAL FILYYTAQGE PFPNNLDKLC GPNVTDFPPF HANGTEKAKL VELYRIVVYL GTSLGNITRD QKILNPSALS LHSKLNATAD ILRGLLSNVL CRLCSKYHVG HVDVTYGPDT SGKDVFQKKK LGCQLLGKYK QIIAVLAQAF |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human LIF |
| Accession Number | P15018 |
| Regulatory Status | RUO |
| Gene Alias | CDF; cholinergic differentiation factor; cholinergic neuronal differentiation factor; d factor; DIA; differentiation inhibitory activity; differentiation-inducing factor; differentiation-stimulating factor; Emfilermin; hepatocyte-stimulating factor III; HILDA; human interleukin in DA cells; leukemia inhibitory factor; leukemia inhibitory factor (cholinergic differentiation factor); LIF; Melanoma-derived LPL inhibitor; MLPLI; myeloid leukaemia inhibitory factor |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of TF-1 cells. |
| Gene ID (Entrez) | 3976 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Activin A |
| Molecular Weight (g/mol) | 26 kDa |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human Activin A |
| Accession Number | P08476 |
| Regulatory Status | GMP |
| Gene Alias | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of mouse MPC-11 cells. PeproGMP Recombinant Human Activin A has been tested against the WHO standard NIBSC 91/626. |
| Gene ID (Entrez) | 3624 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Activity | Determined by the proliferation of mouse Balb/c 3T3 cells. PeproGMP Recombinant Human EGF has been tested against the WHO standard NIBSC 91/530. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human EGF |
| Accession Number | P01133 |
| Regulatory Status | GMP |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by the proliferation of mouse Balb/c 3T3 cells. PeproGMP Recombinant Human EGF has been tested against the WHO standard NIBSC 91/530. |
| Gene ID (Entrez) | 1950 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Activity | Determined by the proliferation of HUVECs. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human VEGF-165 |
| Accession Number | P15692 |
| Regulatory Status | RUO |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of HUVECs. |
| Gene ID (Entrez) | 7422 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BMP4 |
| Molecular Weight (g/mol) | 24.2 kDa |
| Activity | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | MKKNKNCRRH SLYVDFSDVG WNDWIVAPPG YQAFYCHGDC PFPLADHLNS TNHAIVQTLV NSVNSSIPKA CCVPTELSAI SMLYLDEYDK VVLKNYQEMV VEGCGCR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human BMP-4 |
| Accession Number | P12644 |
| Regulatory Status | GMP |
| Gene Alias | BMP; BMP2B; BMP-2B; Bmp2b1; Bmp2b-1; Bmp4; Bmp-4; BOMPR4A; Bone morphogenetic protein; Bone morphogenetic protein 2B; bone morphogenetic protein 4; bone morphogenetic protein 4 preproprotein; DVR4; Dvr-4; MCOPS6; OFC11; ZYME |
| Format | Lyophilized |
| Biological Activity | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. |
| Gene ID (Entrez) | 652 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-15 |
| Molecular Weight (g/mol) | 12.9 kDa |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | MNWVNVISDL KKIEDLIQSM HIDATLYTES DVHPSCKVTA MKCFLLELQV ISLESGDASI HDTVENLIIL ANNSLSSNGN VTESGCKECE ELEEKNIKEF LQSFVHIVQM FINTS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human IL-15 |
| Accession Number | P40933 |
| Regulatory Status | GMP |
| Gene Alias | AI503618; il 15; Il15; IL-15; ILN; Interleukin; interleukin 15; Interleukin15; interleukin-15; MGC9721; M-IL-15 |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of CTLL-2 cells. PeproGMP Recombinant Human IL-15 ha been tested against the WHO standard NIBSC 95/554. |
| Gene ID (Entrez) | 3600 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-3 |
| Molecular Weight (g/mol) | 15 kDa |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | APMTQTTSLK TSWVNCSNMI DEIITHLKQP PLPLLDFNNL NGEDQDILME NNLRRPNLEA FNRAVKSLQN ASAIESILKN LLPCLPLATA APTRHPIHIK DGDWNEFRRK LTFYLKTLEN AQAQQTTLSL AIF |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human IL-3 |
| Accession Number | P08700 |
| Regulatory Status | GMP |
| Gene Alias | BP/BPA; BPA; Colony stimulating factor multiple; colony-stimulating factor, multiple; Csfmu; Eo-CSF; HCGF; hematopoietic growth factor; Il3; Il-3; ILN; Interleukin; interleukin 3; Interleukin 3 (colony stimulating factor; Interleukin3; interleukin-3; Mast cell growth factor; mast-cell growth factor; MCGF; MGC79398; MGC79399; MGF; Multi CSF; MULTI-CSF; Multilineage colony stimulating factor; multilineage-colony-stimulating factor; multiple); multipotential colony-stimulating factor; P cell stimulating factor; P-cell stimulating factor; P-cell-stimulating factor; PCSA; PSF |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of TF-1 cells. PeproGMP Recombinant Human IL-3 ha been tested against the WHO standard NIBSC 91/510. |
| Gene ID (Entrez) | 3562 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-7 |
| Molecular Weight (g/mol) | 17.4 kDa |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | DCDIEGKDGK QYESVLMVSI DQLLDSMKEI GSNCLNNEFN FFKRHICDAN KEGMFLFRAA RKLRQFLKMN STGDFDLHLL KVSEGTTILL NCTGQVKGRK PAALGEAQPT KSLEENKSLK EQKKLNDLCF LKRLLQEIKT CWNKILMGTK EH |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human IL-7 |
| Accession Number | P13232, P16871 |
| Regulatory Status | GMP |
| Gene Alias | A630026I06Rik; H-IL-7; hlb368; IL7; Il-7; ILN; Interleukin; interleukin 7; Interleukin7; interleukin-7; M-IL-7 |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of mouse 2E8 cells. PeproGMP Recombinant Human IL-7 ha been tested against the WHO standard NIBSC 90/530. |
| Gene ID (Entrez) | 3574, 3575 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-2 |
| Molecular Weight (g/mol) | 15.5 kDa |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFAQSII STLT |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human IL-2 |
| Accession Number | P60568 |
| Regulatory Status | GMP |
| Gene Alias | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of mouse CTLL-2 cells. PeproGMP Recombinant Human IL-2 ha been tested against the WHO standard NIBSC 86/500. |
| Gene ID (Entrez) | 3558 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-AA |
| Molecular Weight (g/mol) | 28.5 kDa |
| Activity | Determined by the proliferation of mouse Balb/c 3T3 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SIEEAVPAVC KTRTVIYEIP RSQVDPTSAN FLIWPPCVEV KRCTGCCNTS SVKCQPSRVH HRSVKVAKVE YVRKKPKLKE VQVRLEEHLE CACATTSLNP DYREEDTGRP RESGKKRKRK RLKPT |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human PDGF-AA |
| Accession Number | P04085 |
| Regulatory Status | RUO |
| Gene Alias | H-PDGF-AA; PDGF A-chain; PDGF subunit A; PDGF1; PDGF-1; Pdgfa; PDGF-A; PDGFACP; platelet derived growth factor subunit A; platelet derived growth factor, alpha; Platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor subunit A; Rpa1 |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of mouse Balb/c 3T3 cells. |
| Gene ID (Entrez) | 5154 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-21 |
| Molecular Weight (g/mol) | 15.4 kDa |
| Activity | Determined by the proliferation of ANBL-6 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MQDRHMIRMR QLIDIVDQLK NYVNDLVPEF LPAPEDVETN CEWSAFSCFQ KAQLKSANTG NNERIINVSI KKLKRKPPST NAGRRQKHRL TCPSCDSYEK KPPKEFLERF KSLLQKMIHQ HLSSRTHGSE DS |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human IL-21 |
| Accession Number | Q9HBE4 |
| Regulatory Status | RUO |
| Gene Alias | CVID11; C x 2; il 21; IL21; IL-21; ILN; Interleukin; interleukin 21; Interleukin21; interleukin-21; interleukin-21 isoform; porcine interleukin-21; Za11 |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of ANBL-6 cells. |
| Gene ID (Entrez) | 59067 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-6 |
| Molecular Weight (g/mol) | 20.9 kDa |
| Gene Symbol | Il6 |
| Activity | Determined by the proliferation of mouse 7TD1 cells. PeproGMP Recombinant Human IL-6 has been tested against the WHO standard NIBSC 89/548. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | PVPPGEDSKD VAAPHRQPLT SSERIDKQIR YILDGISALR KETCNKSNMC ESSKEALAEN NLNLPKMAEK DGCFQSGFNE ETCLVKIITG LLEFEVYLEY LQNRFESSEE QARAVQMSTK VLIQFLQKKA KNLDAITTPD PTTNASLLTK LQAQNQWLQD MTTHLILRSF KEFLQSSLRA LRQM |
| Storage Requirements | -20°C or -80°C if preferred |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human IL-6 |
| Accession Number | P05231 |
| Regulatory Status | GMP |
| Purification Method | Purified |
| Gene Alias | B-cell differentiation factor; B-cell hybridoma growth factor; B-cell stimulatory factor 2; BSF2; BSF-2; CDF; CHIL-6; CTL differentiation factor; cytokine; HGF; H-IL-6; HSF; hybridoma growth factor; Ifnb2; IFN-beta-2; Il6; IL-6; ILg6; ILN; interferon beta-2; Interleukin; interleukin 6; Interleukin 6 (interferon, beta 2); interleukin 6 precursor; interleukin BSF-2; interleukin HP-1; Interleukin6; Interleukin-6; interleukin-6 precursor; interleukin-6 protein; M-IL-6; prointerleukin 6; R-IL-6 |
| Product Type | Protein |
| Gene ID (Entrez) | 3569 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Thrombopoietin |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | THPO |
| Activity | Determined by its ability to stimulate human MO7e cell proliferation. PeproGMP Recombinant HumanTPO has been tested against the WHO standard NIBSC 03/124. Find the International Unit (IU) value <a href='https://www.thermofisher.com/us/en/home/life-science/cell-culture/cell-culture-learning-center/recombinant-protein-information/international-units.html'>here</a>. |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Sequence | SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL |
| Storage Requirements | -20°C or -80°C if preferred |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human TPO (Thrombopoietin) |
| Accession Number | P40225 |
| Regulatory Status | GMP |
| Purification Method | Purified |
| Gene Alias | C-mpl ligand; Megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; megakaryocyte stimulating factor; Mgdf; MKCSF; ML; MPL ligand; Mpllg; MSA; Myeloproliferative leukemia virus oncogene ligand; prepro-thrombopoietin; TDH2A; THCYT1; THPO; Thrombopoietin; thyroid microsomal antigen; thyroid peroxidase; thyroperoxidase; Tpo; TPX |
| Product Type | Protein |
| Gene ID (Entrez) | 7066 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 13.5(monomer) kDa |
| Common Name | BDNF |
| Gene Symbol | BDNF |
| Activity | Determined by the proliferation of rat C6 cells. |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | HSDPARRGEL SVCDSISEWV TAADKKTAVD MSGGTVTVLE KVPVSKGQLK QYFYETKCNM GYTKEGCRGI DKRHWNSQCR TTQSYVRALT MDSKKRIGWR FIRIDTSCVC TLTIKRGR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Name | PeproGMP™ Human BDNF |
| Accession Number | P23560 |
| Regulatory Status | GMP |
| Purification Method | Purified |
| Gene Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
| Product Type | Protein |
| Gene ID (Entrez) | 627 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
